Cargando…

Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway

Aberrant glycosylation is frequently observed in cancers. Core 1 β1,3-galactosyltransferase (C1GALT1) is an exclusive enzyme in humans that catalyzes the biosynthesis of core 1 O-glycan structure, Gal-GalNAc-O-Ser/Thr, whose expression is commonly up-regulated during tumorigenesis. Little is known a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chou, Chih-Hsing, Huang, Miao-Juei, Chen, Chi-Hau, Shyu, Ming-Kwang, Huang, John, Hung, Ji-Shiang, Huang, Chiun-Sheng, Huang, Min-Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467426/ https://www.ncbi.nlm.nih.gov/pubmed/25762620

Ejemplares similares

C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2
por: Hung, Ji-Shiang, et al.
Publicado: (2014)

C1GALT1 Promotes Invasive Phenotypes of Hepatocellular Carcinoma Cells by Modulating Integrin β1 Glycosylation and Activity
por: Liu, Chiung-Hui, et al.
Publicado: (2014)

C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
por: Lee, Po-Chu, et al.
Publicado: (2020)

C1GALT1 in health and disease
por: Sun, Xiaojie, et al.
Publicado: (2021)

Update on the role of C1GALT1 in cancer
por: Xia, Tong, et al.
Publicado: (2022)

C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer
por: Lin, Mei-Chun, et al.
Publicado: (2018)

Expression and Impact of C1GalT1 in Cancer Development and Progression
por: Wan, Yangu, et al.
Publicado: (2021)

Germline C1GALT1C1 mutation causes a multisystem chaperonopathy
por: Erger, Florian, et al.
Publicado: (2023)

Structural basis for the synthesis of the core 1 structure by C1GalT1
por: González-Ramírez, Andrés Manuel, et al.
Publicado: (2022)

C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma
por: Lin, Neng-Yu, et al.
Publicado: (2022)

A novel mechanism for C1GALT1 in the regulation of gastric cancer progression
por: Dong, Xiaoxia, et al.
Publicado: (2021)

C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α(v)
por: Kuo, Ting-Chun, et al.
Publicado: (2021)

In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression
por: Montero-Calle, Ana, et al.
Publicado: (2023)

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
por: Huang, Miao-Juei, et al.
Publicado: (2015)

Do the mutations of C1GALT1C1 gene play important roles in the genetic susceptibility to Chinese IgA nephropathy?
por: Li, Gui-Sen, et al.
Publicado: (2009)

C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma
por: Dong, Xiaoxia, et al.
Publicado: (2021)

C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy
por: Xing, Yue, et al.
Publicado: (2020)

The Pattern of Hemoglobin A1C Trajectories and Risk of Herpes Zoster Infection: A Follow-Up Study
por: Pan, Bo-Lin, et al.
Publicado: (2022)

Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway
por: Chen, Po-Da, et al.
Publicado: (2023)

Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways
por: Khiaowichit, Juthamas, et al.
Publicado: (2022)

Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation
por: Zhang, Chuanyi, et al.
Publicado: (2018)

High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia
por: Ren, Zhihong, et al.
Publicado: (2022)

MUC1-C drives DNA methylation in cancer
por: Rajabi, Hasan, et al.
Publicado: (2016)

Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer
por: Tan, Zengqi, et al.
Publicado: (2022)

MUC1-C ACTIVATES BMI1 IN HUMAN CANCER CELLS
por: Hiraki, Masayuki, et al.
Publicado: (2016)

The research status and prospects of MUC1 in immunology
por: Long, Linna, et al.
Publicado: (2023)

Targeted Disruption of Core 1 β1,3-galactosyltransferase (C1galt1) Induces Apical Endocytic Trafficking in Human Corneal Keratinocytes
por: Guzman-Aranguez, Ana, et al.
Publicado: (2012)

Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes
por: Suzuki, Hitoshi, et al.
Publicado: (2014)

Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women
por: Chao, Tai-Hung, et al.
Publicado: (2010)

β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells
por: Che, Mei-Ieng, et al.
Publicado: (2014)

High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma
por: Kuo, Huan-Hsien, et al.
Publicado: (2017)

Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells
por: Huang, H-L, et al.
Publicado: (2017)

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein
por: Jochems, Caroline, et al.
Publicado: (2013)

Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer
por: Kufe, Donald
Publicado: (2023)

MUC1-C ACTIVATES THE TAK1 INFLAMMATORY PATHWAY IN COLON CANCER
por: Takahashi, Hidekazu, et al.
Publicado: (2015)

MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells
por: Huang, Tian-qiao, et al.
Publicado: (2020)

The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression
por: Wang, Bin, et al.
Publicado: (2020)

Correction: Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells
por: Huang, H.-L., et al.
Publicado: (2020)

Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection
por: Paquin-Proulx, Dominic, et al.
Publicado: (2016)

Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma
por: Tagde, Ashujit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_78ukt0ce67tnouhtcm2vauo57u